Skip to content
Sign in

Company

Spectral AI, Inc.

Open structure map

Description

Headquarters
US

Structure of Spectral AI, Inc.

Spectral AI, Inc.

Company

5 connections
UpstreamSupply and dependency
OwnProducts and technology
PeersCompetition and partners
ConstraintsRegulation and exposure
Relationship began2026
Spectral AI, Inc.Company · 5 connections
Layer 1

UpstreamSupply and dependency2

PeersCompetition and partners1

OwnProducts and technology1

ConstraintsRegulation and exposure1

Place in the network

No. 6085 of 118934top 6%down 721 places this week

4 direct links

Weighted by public relations with evidence, recomputed daily.

Relations

Arrows show the direction of the relationship. Filter to focus on a business area.

  • Spectral AI, Inc.uses →DeepView™ System
    Fact90%
    View evidence
    • CompanyGlobeNewswire public company news2026-10-06 20:30
      The DeepView System is a predictive diagnostic device that offers physicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention.
      View source
  • Spectral AI, Inc.drives demand for →DeepView™ System
    Fact90%
    View evidence
    • CompanyGlobeNewswire public company news2026-10-06 20:30
      The Company anticipates a final determination from CMS regarding its application in August 2027. If approved, NTAP payment status would generally be available beginning in October 2027 and continue for approximately three years.
      View source
  • Spectral AI, Inc.depends on →Spectral MD
    Fact90%
    View evidence
    • CompanyGlobeNewswire public company news2026-10-06 20:30
      The Company’s contract with the Biomedical Advanced Research and Development Authority (“BARDA”) is held and performed through its wholly owned subsidiary, Spectral MD.
      View source
  • Spectral AI, Inc.produces →DeepView™ System
    Fact90%
    View evidence
    • CompanyGlobeNewswire public company news2026-10-06 20:30
      Spectral AI's DeepView System is a non-invasive, predictive medical device that combines multispectral imaging with a proprietary AI algorithm to assess the healing potential of areas within burn wounds.
      View source
  • Vincent Caponepart of →Spectral AI, Inc.
    Fact90%
    View evidence
    • CompanyGlobeNewswire public company news2026-10-06 20:30
      “We are investing significant capital in pursuing additional reimbursement pathways as we recognize the importance of supporting hospitals as they incorporate the DeepView System into their clinical workflows and facilitate patient access to care for this innovative technology,”…
      View source
  • Spectral AI, Inc.serves →hospital systems
    Fact90%
    View evidence
    • CompanyGlobeNewswire public company news2026-10-06 20:30
      An NTAP payment, if approved, would represent a meaningful component of the economic value proposition for hospital systems that adopt the DeepView System.
      View source
  • Fact90%
    View evidence
    • CompanyGlobeNewswire public company news2026-10-06 20:30
      today announced the submission of a New Technology Add-On Payment (NTAP) application to the Centers for Medicare & Medicaid Services (CMS) for its DeepView**™** System utilizing the alternative pathway.
      View source
  • Spectral AI, Inc.located in →Dallas
    Fact90%
    View evidence
    • CompanyGlobeNewswire public company news2026-10-06 20:30
      Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns.
      View source
    • CompanyGlobeNewswire public company news2026-10-06 20:30
      DALLAS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- **Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”)**, an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the submissio…
      View source

Showing 1 to 8 of 9

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 1
depends onSpectral MD

The Company’s contract with the Biomedical Advanced Research and Development Authority (“BARDA”) is held and performed through its wholly owned subsidiary, Spectral MD.

GlobeNewswire public company news · 2026-10-06 20:30

View evidence
  • CompanyGlobeNewswire public company news2026-10-06 20:30
    The Company’s contract with the Biomedical Advanced Research and Development Authority (“BARDA”) is held and performed through its wholly owned subsidiary, Spectral MD.
    View source
FactEvidence 1
located inDallas

Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns.

GlobeNewswire public company news · 2026-10-06 20:30

View evidence
  • CompanyGlobeNewswire public company news2026-10-06 20:30
    Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns.
    View source
FactEvidence 1

The DeepView System is a predictive diagnostic device that offers physicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention.

GlobeNewswire public company news · 2026-10-06 20:30

View evidence
  • CompanyGlobeNewswire public company news2026-10-06 20:30
    The DeepView System is a predictive diagnostic device that offers physicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention.
    View source
FactEvidence 1
drives demand forDeepView™ System

The Company anticipates a final determination from CMS regarding its application in August 2027. If approved, NTAP payment status would generally be available beginning in October 2027 and continue for approximately three years.

GlobeNewswire public company news · 2026-10-06 20:30

View evidence
  • CompanyGlobeNewswire public company news2026-10-06 20:30
    The Company anticipates a final determination from CMS regarding its application in August 2027. If approved, NTAP payment status would generally be available beginning in October 2027 and continue for approximately three years.
    View source
FactEvidence 1

“We are investing significant capital in pursuing additional reimbursement pathways as we recognize the importance of supporting hospitals as they incorporate the DeepView System into their clinical workflows and facilitate patient access to care for this innovative technology,”…

GlobeNewswire public company news · 2026-10-06 20:30

View evidence
  • CompanyGlobeNewswire public company news2026-10-06 20:30
    “We are investing significant capital in pursuing additional reimbursement pathways as we recognize the importance of supporting hospitals as they incorporate the DeepView System into their clinical workflows and facilitate patient access to care for this innovative technology,”…
    View source
FactEvidence 1
investmentsignificant capital

“We are investing significant capital in pursuing additional reimbursement pathways as we recognize the importance of supporting hospitals as they incorporate the DeepView System into their clinical workflows and facilitate patient access to care for this innovative technology,”…

GlobeNewswire public company news · 2026-10-06 20:30

View evidence
  • CompanyGlobeNewswire public company news2026-10-06 20:30
    “We are investing significant capital in pursuing additional reimbursement pathways as we recognize the importance of supporting hospitals as they incorporate the DeepView System into their clinical workflows and facilitate patient access to care for this innovative technology,”…
    View source

Showing 1 to 6 of 10

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Suggest a page to watch

Know a page of this company that matters, such as pricing, a changelog, terms or careers? Suggest it. We read every suggestion; a page we add is watched for everyone, and we only count a change when two looks in a row agree.

Sign in to suggest a page

Not available: Company signals · Financials · Filings · Sites · Guidance